Tuberculosis of the breast is an extremely rare disease, which is still present and is also misdiagnosed with carcinoma or bacterial abscesses. In this study, we reported on eight patients with mammary tuberculosis during a four-year period. The main signs and symptoms of the patients included a painful tender lump in the breast (n=4), a painless lump in the breast (n=3), a lump with sinus (n=1), a sinus without lump (n=1), and an ipsilateral axillary lymphadenopathy (n=1). The diagnosis was confirmed by fine-needle aspiration cytology or histology. Antitubercular therapy was the therapeutic mainstay. Surgical intervention was reserved for aspiration of cold abscesses, and excision of residual sinuses and masses.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Paediatric breast disease and developmental breast cysts - reflection on 20 years of experience.
ANZ J Surg
January 2025
Department of Breast and Endocrine Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Introduction: Presentation with breast symptoms in the paediatric population is common but there is little existing literature on the workup and management of breast disease in this population.
Methods: Retrospective series of 140 cases of breast disease in the paediatric population managed by a single surgeon in Adelaide, South Australia between 2004 and 2024. Review of patient demographics, presentation, investigation, management and outcomes of various breast symptoms and pathologies using descriptive analysis.
Prediction of axillary lymph node metastasis in breast cancer using an ultrasonic feature- and clinical data-based model.
Am J Cancer Res
December 2024
Department of General Surgery, Liaoning University of Traditional Chinese Medicine Affiliated Hospital Shenyang 110032, Liaoning, China.
The involvement of axillary lymph nodes (ALNs) is a critical prognostic factor affecting patient management and outcomes in breast cancer (BC). This study aims to comprehensively analyze the clinical data of BC patients, evaluate ultrasonic signs of ALNs, and explore the implications of a prediction model for ALN metastasis (ALNM) in early-stage BC patients based on ultrasonic features and clinical data. This study retrospectively analyzed ultrasonic features and clinical data from 216 patients diagnosed with unilateral invasive BC.
View Article and Find Full Text PDFCarcinoma Breast Presenting with Concurrent Extensive Lymph Nodal Sarcoidosis.
Indian J Nucl Med
November 2024
Department of Nuclear Medicine, SGPGIMS, Lucknow, Uttar Pradesh, India.
Sarcoidosis is a systemic disease characterized by noncaseating granulomas involving any organ. Concurrent carcinoma breast with sarcoidosis is a rare occurrence. A 51-year-old female presented with right breast lump and was diagnosed with infiltrating ductal carcinoma with lymph nodal (LN) metastases (estrogen receptor, progesterone receptor positive, and HER2neu negative).
View Article and Find Full Text PDFTreatment of idiopathic granulomatous mastitis: a retrospective case series.
Rheumatol Int
January 2025
Division of Rheumatology, Centre hospitalier de l'Université de Montréal (CHUM), Department of Medicine, Université de Montréal, Montreal, Canada.
Idiopathic granulomatous mastitis (IGM) is a rare inflammatory disease of the breast. Various clinical management approaches have been described, but their efficacy and optimal sequential order remain uncertain. We describe the first Canadian cohort of patients with IGM, discuss treatment outcomes and outline a practical management approach.
View Article and Find Full Text PDFPathway to care among adolescents and young adults with breast cancer in Nigeria: a mixed methods study.
BMC Cancer
January 2025
Department of Radiation Biology, Radiotherapy & Radiodiagnosis, College of Medicine, University of Lagos, Lagos, Nigeria.
Background: The mortality from breast cancer (BC) is still high in Nigeria and other low-and medium-income countries (LMICs) especially among adolescents and young adults. This is partly due to late presentation for diagnosis and treatment. It is recommended that to optimize the effectiveness of treatment, the total time which is the interval from symptom onset to initiation of treatment, should be less than 90 days as recommended by the World Health Organization (WHO).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!